Immune targeting strategy using anti-IL-7R antibody-drug conjugate (A7R-ADC)

被引：0
|
作者：
Yang, Shiqi [1 ]
Manabe, Shino [2 ]
Yasunaga, Masahiro
机构：
[1] Natl Canc Ctr, EOR&CT Ctr, Div Dev Therap, Tokyo, Japan
[2] Hoshi Univ, Dept Pharm, Lab Funct Mol Chem, Tokyo, Japan
来源：
CANCER SCIENCE | 2021年 / 112卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PJ12-5-3
引用
收藏
页码：744 / 744
页数：1
相关论文
共 50 条
  • [31] A Phage Display-Generated Fully Human Anti-IL-7Rα Antibody Shows Anti-Tumor Activity Against T-Cell Acute Lymphoblastic Leukemia
    Akkapeddi, Padma
    Fragoso, Ana Rita
    Hixon, Julie
    Oliveira, Mariana
    Carvalho, Tania
    Gloger, Andreas
    Matasci, Mattia
    Corzana, Francisco
    Durum, Scott
    Neri, Dario
    Bernardes, Goncalo
    Barata, Joao
    BLOOD, 2018, 132
  • [32] Preclinical development of a duocarmycin-based antibody-drug conjugate targeting B7-H3 for solid cancer
    Son, Thomas
    Scribner, Juniper A.
    Hooley, Jeff
    Chiechi, Michael
    Li, Pam
    Hotaling, Timothy E.
    De Costa, Anushka
    Chen, Yan
    Chen, Francine
    Barat, Bhaswati
    Ciccarone, Valentina
    Gaynutdinov, Timur
    Tamura, James
    Koenig, Scott
    Johnson, Syd
    Moore, Paul A.
    Bonvini, Ezio
    Loo, Deryk
    CANCER RESEARCH, 2017, 77
  • [33] A B7-H4 targeting antibody-drug conjugate shows anti-tumor activity in PARPi and platinum resistant cancers with B7-H4 expression
    Gitto, Sarah B.
    Whicker, Margaret
    Davies, Gareth
    Kumar, Sushil
    Kinneer, Krista
    Lewis, Arthur
    Mamidi, Srinivas
    Medvedev, Sergey
    Anderton, Judith
    Tang, Jessica
    Ferman, Benjamin
    Coats, Steve
    Wilkinson, Robert W.
    Brown, Eric J.
    Powell, Daniel J.
    Simpkins, Fiona
    CANCER RESEARCH, 2023, 83 (07)
  • [34] Targeting B7-H3 in prostate cancer: Preclinical proof of concept with MGC018, an investigational anti-B7-H3 antibody-drug conjugate
    Scribner, Juniper A.
    Chen, Francine Z.
    De Costa, Anushka
    Li, Ying
    Chiechi, Michael
    Son, Thomas
    Hooley, Jeff
    Li, Jonathan
    Koenig, Scott
    Bohac, Chet
    Bonvini, Ezio
    Moore, Paul A.
    Loo, Deryk
    CANCER RESEARCH, 2022, 82 (12)
  • [35] ACTIVITY, SAFETY AND TOLERABILITY OF ANTIBODY-DRUG CONJUGATE (ADC) SGN-35 IN RELAPSED/REFRACTORY (R/R) HODGKIN LYMPHOMA (HL) AND CD30+ HEMATOLOGIC MALIGNANCIES
    McCarty, J. M.
    Sureda, A.
    Sweetenham, J.
    Moskowitz, C. H.
    Kennedy, D.
    Sievers, E. L.
    HAEMATOLOGICA, 2010, 95 : S28 - S28
  • [36] Pre-clinical evaluation of a novel antibody drug conjugate (ADC) LM-306 targeting IL-13Rα2 in immuno-oncology
    Huang, Wentao
    Liu, Zhifang
    Li, Yifan
    Pan, Heng
    Li, Yuan
    Qin, Xia
    Fei, Da
    Li, Runsheng
    CANCER RESEARCH, 2023, 83 (07)
  • [37] 2 for 1: Targeting tumor-associated macrophages and cancer cells with a novel MERTK-targeting antibody-drug conjugate (ADC)
    Takeda, Shugaku
    Lo, PuiChi
    Schefer, Daniel
    Siddiqui, Maryam
    Tyagi, Anudishi
    Battula, Venkata Lokesh
    Maiti, Abhishek
    Tavazoie, Sohail
    Tavazoie, Masoud
    Darst, David Martin
    Kurth, Isabel
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [38] MBRC-101: a novel antibody-drug conjugate (ADC) targeting the tyrosine kinase receptor EphA5
    Staquicini, Fernanda I.
    Tang, Fenny H.
    de Oliveira, Vanessa
    Staquicini, Daniela I.
    Wu, Yongjian
    Barnhart, Kirstin F.
    Parsons, J. Kellogg
    Arap, Wadih
    Chen, Isan
    Pasqualini, Renata
    CANCER RESEARCH, 2024, 84 (06)
  • [39] Tumor-targeted immune activation via a site-specific TLR7-agonist antibody-drug conjugate
    Kang, Mingchao
    Moon, Sung-Ju
    Kim, Ji Young
    Beck, Andy
    Allen, Molly
    Nelson, Jay
    Tatsukawa, Keith
    Tran, Hon
    Pal, Manoj
    Gray, Michael
    Knudsen, Nick
    Skidmore, Lillian
    Mills, David
    Lu, Yingchun
    Buechler, Ying
    Sakamuri, Sukumar
    Zhang, Shawn
    Tian, Feng
    CANCER RESEARCH, 2022, 82 (12)
  • [40] Toward clinical development of SYD985, a novel HER2-targeting antibody-drug conjugate (ADC).
    Verheijden, Gijs
    Beusker, Patrick
    Ubink, Ruud
    van der Lee, Miranda
    Groothuis, Patrick
    Goedings, Peter J.
    Egging, David
    Mattaar, Ellen
    Timmers, Macro
    Dokter, Wim
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345